Back to PI Prime Capital Investment Advisors, LLC

ABBV

Showing 8 of 28 quarters

Position history for PIPrime Capital Investment Advisors, LLC's holdings in AbbVie Inc.

Yes. Prime Capital Investment Advisors holds 124,698 shares of ABBV (AbbVie), worth $32.6M, as of its Q3 2026 13F filing. It reduced the position by 3,811 shares (-3.0%) from Q2 2026. Prime Capital Investment Advisors has listed ABBV in each of its last 28 quarterly 13F filings. ABBV is 0.3% of Prime Capital Investment Advisors' reported 13F portfolio.

Current Value

$32.6M

Current Shares

124,698

Total Value Change

+$10.1M

Total Shares Change

-2,122

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
124,698
-3.0%
$32.6M0.3%$259.99
0
2026-Q2
Decreased
128,509
-2.3%
$32.3M0.3%$248.34
0
2026-Q1
Increased
131,500
+1.4%
$28.6M0.3%$212.87
35
2025-Q4
Increased
129,618
+0.8%
$29.6M0.4%$221.85
35
2025-Q3
Increased
128,590
+3.0%
$29.8M0.4%$223.20
35
2025-Q2
Decreased
124,831
-19.7%
$23.2M0.3%$177.40
0
2025-Q1
Increased
155,398
+22.5%
$32.6M0.4%$198.41
42
2024-Q4
Decreased
126,820
-5.7%
$22.5M0.3%$166.71
0

Other major holders of ABBV: Vanguard Group Inc., BlackRock, Inc.

Optional analytics helps us improve. How it’s used